RenovoRx, Inc. (RNXT)

NASDAQ: RNXT · IEX Real-Time Price · USD
1.400
+0.020 (1.45%)
Mar 28, 2024, 3:59 PM EDT - Market closed

Total Valuation

RenovoRx has a market cap or net worth of $21.88 million. The enterprise value is $18.65 million.

Market Cap 21.88M
Enterprise Value 18.65M

Important Dates

The next estimated earnings date is Monday, May 13, 2024, before market open.

Earnings Date May 13, 2024
Ex-Dividend Date n/a

Share Statistics

RenovoRx has 10.69 million shares outstanding. The number of shares has increased by 17.93% in one year.

Shares Outstanding 10.69M
Shares Change (YoY) +17.93%
Shares Change (QoQ) +0.36%
Owned by Insiders (%) 18.57%
Owned by Institutions (%) 3.10%
Float 9.43M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 3,645.85
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.19, with zero debt.

Current Ratio 2.19
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 655.36

Financial Efficiency

Return on equity (ROE) is -345.30% and return on invested capital (ROIC) is -196,483.33%.

Return on Equity (ROE) -345.30%
Return on Assets (ROA) -169.20%
Return on Capital (ROIC) -196,483.33%
Revenue Per Employee n/a
Profits Per Employee -$916,100
Employee Count 10
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -56.77% in the last 52 weeks. The beta is 1.12, so RenovoRx's price volatility has been higher than the market average.

Beta (1Y) 1.12
52-Week Price Change -56.77%
50-Day Moving Average 1.44
200-Day Moving Average 1.44
Relative Strength Index (RSI) 42.95
Average Volume (30 Days) 74,116

Short Selling Information

The latest short interest is 15,634, so 0.15% of the outstanding shares have been sold short.

Short Interest 15,634
Short Previous Month 6,835
Short % of Shares Out 0.15%
Short % of Float 0.17%
Short Ratio (days to cover) 0.12

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -11.79M
Pretax Income -9.16M
Net Income -9.16M
EBITDA -9.18M
EBIT -9.18M
Earnings Per Share (EPS) -$0.94
Full Income Statement

Balance Sheet

The company has $3.23 million in cash and no debt, giving a net cash position of $3.23 million or $0.30 per share.

Cash & Cash Equivalents 3.23M
Total Debt n/a
Net Cash 3.23M
Net Cash Per Share $0.30
Equity / Book Value 6,000
Book Value Per Share 0.00
Working Capital 1.91M
Full Balance Sheet

Cash Flow

Operating Cash Flow -9.89M
Capital Expenditures n/a
Free Cash Flow -9.89M
FCF Per Share -$0.93
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

RenovoRx does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -17.93%
Shareholder Yield -17.93%
Earnings Yield -41.88%
FCF Yield -45.19%

Analyst Forecast

The average price target for RenovoRx is $4.00, which is 185.71% higher than the current price. The consensus rating is "Buy".

Price Target $4.00
Price Target Difference 185.71%
Analyst Consensus Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a